Aging of blood can be tracked by DNA methylation changes at just three CpG sites CI Weidner, Q Lin, CM Koch, L Eisele, F Beier, P Ziegler, DO Bauerschlag, ... Genome biology 15, 1-12, 2014 | 883 | 2014 |
Molecular and prognostic distinction between serous ovarian carcinomas of varying grade and malignant potential I Meinhold-Heerlein, D Bauerschlag, F Hilpert, P Dimitrov, LM Sapinoso, ... Oncogene 24 (6), 1053-1065, 2005 | 245 | 2005 |
One-step nucleic acid amplification—a molecular method for the detection of lymph node metastases in breast cancer patients; results of the German study group C Schem, N Maass, DO Bauerschlag, MH Carstensen, T Löning, C Roder, ... Virchows Archiv 454, 203-210, 2009 | 141 | 2009 |
Fatty acid synthase overexpression: target for therapy and reversal of chemoresistance in ovarian cancer DO Bauerschlag, N Maass, P Leonhardt, FA Verburg, U Pecks, ... Journal of translational medicine 13, 1-12, 2015 | 116 | 2015 |
Maternal and fetal cord blood lipids in intrauterine growth restriction U Pecks, M Brieger, B Schiessl, DO Bauerschlag, D Piroth, B Bruno, ... De Gruyter 40 (3), 287-296, 2012 | 111 | 2012 |
Evaluation of the effects of sensorimotor exercise on physical and psychological parameters in breast cancer patients undergoing neurotoxic chemotherapy PL Vollmers, C Mundhenke, N Maass, D Bauerschlag, S Kratzenstein, ... Journal of cancer research and clinical oncology 144, 1785-1792, 2018 | 92 | 2018 |
Tribody [(HER2)2xCD16] Is More Effective Than Trastuzumab in Enhancing γδ T Cell and Natural Killer Cell Cytotoxicity Against HER2-Expressing Cancer Cells HH Oberg, C Kellner, D Gonnermann, S Sebens, D Bauerschlag, ... Frontiers in immunology 9, 814, 2018 | 90 | 2018 |
A phase II trial (AGO 2.11) in platinum-resistant ovarian cancer: a randomized multicenter trial with sunitinib (SU11248) to evaluate dosage, schedule, tolerability, toxicity … KH Baumann, A Du Bois, W Meier, J Rau, P Wimberger, J Sehouli, ... Annals of oncology 23 (9), 2265-2271, 2012 | 89 | 2012 |
An integrated clinical-genomics approach identifies a candidate multi-analyte blood test for serous ovarian carcinoma I Meinhold-Heerlein, D Bauerschlag, Y Zhou, LM Sapinoso, K Ching, ... Clinical cancer research 13 (2), 458-466, 2007 | 76 | 2007 |
In vitro effects of imatinib mesylate on radiosensitivity and chemosensitivity of breast cancer cells MT Weigel, L Dahmke, C Schem, DO Bauerschlag, K Weber, P Niehoff, ... BMC cancer 10, 1-14, 2010 | 67 | 2010 |
Progression-free survival in ovarian cancer is reflected in epigenetic DNA methylation profiles DO Bauerschlag, O Ammerpohl, K Bräutigam, C Schem, Q Lin, MT Weigel, ... Oncology 80 (1-2), 12-20, 2011 | 58 | 2011 |
Benign abdominal and pulmonary metastasizing leiomyoma of the uterus JH Egberts, C Schafmayer, DO Bauerschlag, U Jänig, J Tepel Archives of gynecology and obstetrics 274, 319-322, 2006 | 58 | 2006 |
The evaluation of the oxidative state of low-density lipoproteins in intrauterine growth restriction and preeclampsia U Pecks, R Caspers, B Schiessl, D Bauerschlag, D Piroth, N Maass, ... Hypertension in Pregnancy 31 (1), 156-165, 2012 | 56 | 2012 |
Final results from GCIG/ENGOT/AGO‐OVAR 12, a randomised placebo‐controlled phase III trial of nintedanib combined with chemotherapy for newly diagnosed advanced ovarian cancer I Ray‐Coquard, D Cibula, MR Mirza, A Reuss, C Ricci, N Colombo, ... International journal of cancer 146 (2), 439-448, 2020 | 47 | 2020 |
Negative 18F-2-fluorodeoxyglucose PET/CT predicts good cancer specific survival in patients with a suspicion of recurrent ovarian cancer CB Hebel, FF Behrendt, A Heinzel, T Krohn, FM Mottaghy, ... European journal of radiology 83 (3), 463-467, 2014 | 43 | 2014 |
Bispecific antibodies enhance tumor-infiltrating T cell cytotoxicity against autologous HER-2-expressing high-grade ovarian tumors HH Oberg, L Janitschke, V Sulaj, J Weimer, D Gonnermann, N Hedemann, ... Journal of leukocyte biology 107 (6), 1081-1095, 2020 | 42 | 2020 |
A specific photoimmunotheranostics agent to detect and eliminate skin cancer cells expressing EGFR V von Felbert, D Bauerschlag, N Maass, K Bräutigam, I Meinhold-Heerlein, ... Journal of cancer research and clinical oncology 142, 1003-1011, 2016 | 42 | 2016 |
Quantifying cell free DNA in urine: comparison between commercial kits, impact of gender and inter-individual variation G Streleckiene, HM Reid, N Arnold, D Bauerschlag, M Forster Biotechniques 64 (5), 225-230, 2018 | 39 | 2018 |
Integration and validation of hysteroscopy simulation in the surgical training curriculum M Elessawy, M Skrzipczyk, C Eckmann-Scholz, N Maass, L Mettler, ... Journal of surgical education 74 (1), 84-90, 2017 | 38 | 2017 |
Primary pulmonary choriocarcinoma: case report and review of the literature J Serno, F Zeppernick, J Jäkel, S Schrading, N Maass, ... Gynecologic and Obstetric Investigation 74 (2), 171-176, 2012 | 38 | 2012 |